NeoGenomics, Inc. - Common Stock (NQ:NEO)

17.25 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action on Behalf of Investors in NeoGenomics, Inc. and Advises Shareholders with Losses of $100,000 to Contact the Firm

December 06, 2022

From The Schall Law Firm

Via Business Wire

NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 05, 2022

Via ACCESSWIRE

NeoGenomics Announces Chief Financial Officer Transition

December 05, 2022

Via ACCESSWIRE

Big Developments Set to be Unveiled at This Year’s San Antonio Breast Cancer Symposium (SABCS)

November 30, 2022

EQNX::TICKER_START (NASDAQ:ONCY),(NYSE:LLY),(NASDAQ:NEO),(NYSE:ZYME),(NASDAQ:GTHX) EQNX::TICKER_END

Via FinancialNewsMedia

Why Shares of NeoGenomics Jumped 53.9% This Week ↗

November 11, 2022

The cancer screening company showed its turnaround may be working.

Via The Motley Fool

Where NeoGenomics Stands With Analysts ↗

November 09, 2022

Within the last quarter, NeoGenomics (NASDAQ:NEO) has observed the following analyst ratings:

Via Benzinga

RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease

November 21, 2022

Via ACCESSWIRE

NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE(TM)

November 18, 2022

Via ACCESSWIRE

BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday ↗

November 17, 2022

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81% ↗

November 11, 2022

Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to...

Via Benzinga

Earnings Scheduled For November 11, 2022 ↗

November 11, 2022

Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is expected to report quarterly loss at $0.37 per share on revenue of $919.90 million.

Via Benzinga

NeoGenomics Reports Third Quarter 2022 Results

November 08, 2022

Via ACCESSWIRE

Stocks That Hit 52-Week Lows On Thursday ↗

October 20, 2022

Thursday saw 177 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗

November 09, 2022

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.

Via Benzinga

NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022

September 07, 2022

Via ACCESSWIRE

Turnaround For This Cancer Genetics Testing Firm Could Take Years, Analyst Says While Downgrading Stock ↗

August 22, 2022

Via Benzinga

DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday ↗

November 09, 2022

U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 08, 2022

Gainers

Via Benzinga

NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors

November 07, 2022

Via ACCESSWIRE

Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session ↗

November 08, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...

Via Benzinga

If You Invested $1,000 In These 3 Crypto Tokens You Would Have This Much In Crypto Dividends ↗

October 28, 2022

When navigating the cryptocurrency market it can be difficult to distinguish between the “s— tokens” and tokens that actually provide value through a utility.

Via Benzinga

NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch

October 28, 2022

Via ACCESSWIRE

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗

October 26, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Via Benzinga

Aaron's, Celestica, Medpace Holdings And Some Other Big Stocks Moving Higher On Tuesday ↗

October 25, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Starbucks Plunges As Xi Jinping Consolidates Power: Here's What's Going On ↗

October 24, 2022

Starbucks Corporation (NASDAQ: SBUX) was sliding about 6% lower on Monday in tandem with a number of China-based stocks.

Via Benzinga

NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022

October 13, 2022

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2022 ↗

August 26, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022 ↗

August 22, 2022

Upgrades

Via Benzinga

Target To $200? Here Are 5 Other Price Target Changes For Thursday ↗

August 18, 2022

Raymond James raised the price target on Target Corporation (NYSE: TGT) from $190 to $200. However, Raymond James analyst Bobby Griffin maintained the stock with a Strong Buy. Target shares fell 0.1%...

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.